Cancer patient who pushed for drug pricing reform isn't done yet; inside an effort to diversify genomic databases

David Mitchell is a cancer patient and former political PR expert who volunteered to become the face of the opposition to the pharma industry.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

STAT+: Cancer patient who devoted six years to drug pricing reform isn't done yet By Rachel Cohrs Chip Somodevilla/Getty Images David Mitchell of Patients for Affordable Drugs was willing to face off against pharma's heavyweights. Now he has a win. Read More A team of Oxford and Mexican researchers want to diversify genomic databases. Can they end 'parachute science,' too? By Emiliano Rodríguez Mega ALFREDO ESTRELLA/AFP via Getty Images While Oxford has physical custody of all the samples, Mexican epidemiologists actively participated in almost every step of the research. Read More Opinion: Report: More people should be tested for potential exposure to 'forever chemicals' By Ned Calonge and Jane Hoppin and Alex R. Kemper Jim Cole/ AP Photo A new report offers a guide for clinicians and the public about testing for PFAS ("forever chemicals") that many people have been exposed to. Read More Sponsor content by Salesforce STAT E-Book: How technology shapes patient experiences Our latest e-book underscores the vast range of technologies that are shaping how patients find and receive health care, from smartphone apps to deliver therapy and bedside bots to channel medication requests to new tools to collect real-world data and wearable watches to detect heart health. These stories illustrate the exciting advances being made on these technologies, and highlight the challenges to their broader adoption. Download now. Opinion: Real-world data can help expedite drug approvals for serious diseases with few options By Elenee Argentinis Adobe Connecting real-world data from participants in registration trials can expedite the path to validating effectiveness and safety. Read More STAT+: Federal judge dismisses doctor's case that argued surprise billing law was unconstitutional By Bob Herman Adobe In a consequential ruling, a federal judge has upheld the surprise billing law, saying it does not violate the rights of a New York surgeon. Read More Tuesday, August 16, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser